Lumiera begins fiscal year strong with +25% growth in Q1 2022 compared to the previous year
By IHR Magazine, . Updated
The increase in the Company’s sales has been driven by the new sales and in-store training team deployed late last year. The team is helping build distribution and training key in-store influencers on the benefits of Lumiera’s products. In addition, Lumiera is continuing to build online sales with e-retailers such as Amazon and Lumiera’s own Holizen.ca and Awaye.ca websites.
“Following the launch of the new corporate strategy developed in the first half of 2021, I’m very pleased to say that the growth we began to experience in Q3’21 led to record sales in Q4’21, and another strong quarter in Q1’22. Based on our success, we are increasing our investment in inventory to enable us to capitalize on additional growth opportunities. From a profitability perspective, we are particularly excited by the fact that our growth is also leading to increased margins,” says Carlos Ponce, CEO of Lumiera. “Moving forward, we are laser-focused on increasing our retail and online distribution; based on the positive feedback we have from people that have tried our Bazzzics sleep aids and Awaye pain relief cream, we know that distribution expansion leads to accelerated sales growth and we expect revenues to increase exponentially.”
Management will continue executing its plan for growth and expects to see the upward sales trends continue for the foreseeable future.
Sections: Industry News
More in Industry News
- Jungbunzlauer’s New Director Lands in the Middle of a Citric Acid Duty Fight
- NHP labelling Bulletin 13 turns two relabels into one reprint
- CHFA Launch Pad 2026 : deux finalistes québécois, et ni l’un ni l’autre n’a besoin d’une licence de Santé Canada
- CHFA Launch Pad 2026: Canada’s Innovation Pipeline Has Left the Supplement Aisle
- Retailers Want Inventory AI. Almost None Have It.
- The Ingredient Aisle Is Reorganising Around Proof — and That’s Where Niche Retailers Win